首页> 外文期刊>Journal of Atrial Fibrillation >Complexities in the Atrial Fibrillation-Stroke Relationship: Improving Comprehension of Temporal Discordance, Magnitude Synergism, and Subclinical Atrial Fibrillation -- Three Sources of Consternation for Physicians Who Care for Patients with Atrial Fibrillation
【24h】

Complexities in the Atrial Fibrillation-Stroke Relationship: Improving Comprehension of Temporal Discordance, Magnitude Synergism, and Subclinical Atrial Fibrillation -- Three Sources of Consternation for Physicians Who Care for Patients with Atrial Fibrillation

机译:心房颤动-卒中关系的复杂性:提高对时间不一致,幅度协同作用和亚临床心房颤动的理解-护理心房颤动患者的医师的三种养生来源

获取原文
           

摘要

That clinically-documented atrial fibrillation (AF) in association with a variety of elevated clinical/laboratory risk markers is associated with an increased risk of stroke is well known -- regardless of whether the AF is paroxysmal, persistent, or permanent. Moreover, data is accumulating to suggest that the absolute rate of stroke should be expectedly higher with a greater burden of AF and greater degree of comorbid contributors. Relatedly, stroke prevention with chronic oral anticoagulation (OAC) is recommended for AF patients with appropriate risk markers by all major medical, cardiologic, and surgical guideline-writing organizations. However, at least two major clinical concerns about the above AF-stroke statements remain. First, if AF is related to stroke, why then is there not a consistent temporal relationship between a stroke and AF? Second, is there importance to and what should we do about device-detected AF (so-called subclinical AF [SCAF]) in the absence of clinically-recognized AF? This paper is designed to enhance the understanding of these issues and reduce the consternation of physicians who care for patients with AF with respect to them.
机译:众所周知,无论房颤是阵发性,持续性还是永久性的,临床记录的房颤(AF)与各种升高的临床/实验室风险标志物都与中风风险增加相关。此外,越来越多的数据表明,卒中的绝对发生率应更高,房颤负担更大,共病贡献者的程度更高。相关地,所有主要的医学,心脏病学和外科手术指南编写组织均建议对具有适当危险标志物的房颤患者建议采用慢性口服抗凝(OAC)预防中风。然而,关于上述AF中风的陈述至少有两个主要的临床问题。首先,如果AF与中风有关,那么为什么中风和AF之间没有一致的时间关系?第二,在没有临床公认的AF的情况下,对于设备检测到的AF(所谓的亚临床AF [SCAF])有什么重要性,我们该怎么办?本文旨在增强对这些问题的理解,并减少照顾AF患者的医师的疑虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号